아리피프라졸불순물19

아리피프라졸불순물19
아리피프라졸불순물19 구조식 이미지
카스 번호:
203395-78-2
한글명:
아리피프라졸불순물19
동의어(한글):
아리피프라졸불순물19
상품명:
Aripiprazole Impurity 19
동의어(영문):
Valine Impurity 12;Aripiprazole (IMP F);Aripiprazole Impurity 19;Aripiprazole impurities1769;5-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl);1-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl);8-(4-bromobutoxy)-3,4-dihydroquinolin-2(1H)-one;2(1H)-Quinolinone, 5-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-;5-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one (Aripiprazole Impurity);5-?[4-?[4-?(2,?3-?Dichlorophenyl)?-?1-?piperazinyl]?butoxy]?-?3,?4-?dihydro-2(1H)?-?quinolinone (Aripiprazole Impurity)
CBNumber:
CB63054257
분자식:
C23H27Cl2N3O2
포뮬러 무게:
448.39
MOL 파일:
203395-78-2.mol

아리피프라졸불순물19 속성

안전

아리피프라졸불순물19 C화학적 특성, 용도, 생산

용도

5-?[4-?[4-?(2,?3-?Dichlorophenyl)?-?1-?piperazinyl]?butoxy]?-?3,?4-?dihydro-2(1H)?-?quinolinone is an impurity of Aripiprazole, an anti-psychotic drug, Aripiprazole (A771000).

아리피프라졸불순물19 준비 용품 및 원자재

원자재

준비 용품


아리피프라졸불순물19 공급 업체

글로벌( 32)공급 업체
공급자 전화 이메일 국가 제품 수 이점
CR Corporation Lomited

fred.wen@crcorporation.cn CHINA 12069 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Shanghai Xiang Xin Industrial Co., Ltd. 021-50211651 13651607026
sales@xxgmpharm.com China 498 58
S.Z. PhyStandard Bio-Tech. Co., Ltd. 0755-4000505016 13380397412
3001272453@qq.com China 5059 50
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-010-52878169 15801002657
sales@bjcomparison.com China 4791 58
ChemStrong Scientific Co.,Ltd 0755-0755-66853366 13670046396
sales@chem-strong.com China 17995 56
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9911 50
Nanjing XiZe Biotechnology CO., Ltd. 025-66023220 0086-15250997978
1511893459@qq.com China 7774 55
BOC Sciences 16314854226
info@bocsci.com United States 9926 65
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 8256 55

Copyright 2019 © ChemicalBook. All rights reserved